h-header

news

News dal mondo

26

Nov

Generic drug manufacturing on rebound - FDA witnesses uptick in facility registrations

After years of witnessing a steady decline in generic drug manufacturing facility registrations with the US Food and Drug Administration (FDA), it seems that in 2021 the numbers will once again witness an increase, albeit marginally.

  PharmaCompass analyzed the FDA database of facilities that have paid the user fee under the Generic Drug User Fee Act (GDUFA)....[PharmaCompass]

 

26

Nov

Generic drug manufacturing on rebound - FDA witnesses uptick in facility registrations

After years of witnessing a steady decline in generic drug manufacturing facility registrations with...

25

Nov

EC’s new pharmaceutical strategy highlights support for innovation, R&D

The European Commission (EC) has adopted its pharmaceutical strategy for Europe. The announcement...

23

Nov

Covid-19, ministro Speranza firma due nuove Ordinanze per contrastare la diffusione del virus

La prima Ordinanza, firmata il 19 novembre e già in vigore, rinnova fino...

23

Nov

WTO Divided Over Suspending Protection Of COVID-19 IP

A meeting of World Trade Organization members on Friday revealed deep divisions over a proposal from...

slider-banner

h-footer
pager